Side of Embryo Biopsy Interfering Implantation Potential
Effect of Embryo Biopsy Side on Post Biopsy Blastocyst Structurs and Implantation
1 other identifier
interventional
100
2 countries
2
Brief Summary
Selection of side of embryo biopsy that will not interfering with implantation power of developed blastocyst embryo during biopsy procedure arranged for PGT.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2015
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedFirst Submitted
Initial submission to the registry
September 7, 2016
CompletedFirst Posted
Study publicly available on registry
September 16, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 2, 2018
CompletedJanuary 15, 2019
January 1, 2019
3.9 years
September 7, 2016
January 12, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
blastocyst location of ICM at day 5
describing the location of the inner cell mass (ICM) in location to the zona peluceda (ZP) drilling opening.
2 months
Secondary Outcomes (1)
Implantation power
2 months
Study Arms (2)
Vegetal Pole blastomer embryo
EXPERIMENTALfor day 3 embryo biopsy / cleavage stage: Blastomere collection from opposite side to the 2nd polar body or from vegetal pole.
Animal Pole blastomer embryo
EXPERIMENTALfor day 3 embryo biopsy / cleavage stage: Blastomere collection from and side around the 2nd polar body and not the vegetal pole.
Interventions
for day 3 embryo biopsy / cleavage stage
for day 3 embryo biopsy / cleavage stage
Eligibility Criteria
You may qualify if:
- grade 1 or 2 embryos at eight cell stage or 8-1/ 8-2 embryo quality.
You may not qualify if:
- grade 3 embryo at day 3, or 8-3 embryos.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ahmad Mustafa Mohamed Metwalleylead
- Ibn Sina Hospitalcollaborator
Study Sites (2)
AHMAD Barakat
Manama, 15006, Bahrain
Ibn Sina IVF Center- Ibn Sina Hospital
Sohag, 15006, Egypt
Related Publications (6)
Tscherne RJ, Capitano G. High-pressure liquid chromatographic separation of pharmaceutical compounds using a mobile phase containing silver nitrate. J Chromatogr. 1977 Jun 11;136(2):337-41. doi: 10.1016/s0021-9673(00)86290-1. No abstract available.
PMID: 195970RESULTGeraedts J, Sermon K. Preimplantation genetic screening 2.0: the theory. Mol Hum Reprod. 2016 Aug;22(8):839-44. doi: 10.1093/molehr/gaw033. Epub 2016 Jun 2.
PMID: 27256482RESULTBalakier H, Sojecki A, Motamedi G, Librach C. Impact of multinucleated blastomeres on embryo developmental competence, morphokinetics, and aneuploidy. Fertil Steril. 2016 Sep 1;106(3):608-614.e2. doi: 10.1016/j.fertnstert.2016.04.041. Epub 2016 May 18.
PMID: 27206619RESULTCimadomo D, Capalbo A, Ubaldi FM, Scarica C, Palagiano A, Canipari R, Rienzi L. The Impact of Biopsy on Human Embryo Developmental Potential during Preimplantation Genetic Diagnosis. Biomed Res Int. 2016;2016:7193075. doi: 10.1155/2016/7193075. Epub 2016 Jan 28.
PMID: 26942198RESULTWang Z, Ang WT, Tan SY, Latt WT. Automatic segmentation of zona pellucida and its application in cleavage-stage embryo biopsy position selection. Annu Int Conf IEEE Eng Med Biol Soc. 2015;2015:3859-64. doi: 10.1109/EMBC.2015.7319236.
PMID: 26737136RESULTDahdouh EM, Balayla J, Audibert F; Genetics Committee; Wilson RD, Audibert F, Brock JA, Campagnolo C, Carroll J, Chong K, Gagnon A, Johnson JA, MacDonald W, Okun N, Pastuck M, Vallee-Pouliot K. RETIRED: Technical Update: Preimplantation Genetic Diagnosis and Screening. J Obstet Gynaecol Can. 2015 May;37(5):451-63. doi: 10.1016/s1701-2163(15)30261-9.
PMID: 26168107RESULT
Related Links
- Oct4 and Sox2 Directly Regulate Expression of Another Pluripotency Transcription Factor, Zfp206, in Embryonic Stem Cells
- Oct4/Sox2 Binding Sites Contribute to Maintaining Hypomethylation of the Maternal Igf2/H19 Imprinting Control Region
- Formation of Pluripotent Stem Cells in the Mammalian Embryo Depends on the POU Transcription Factor Oct4
- Multipotent cell lineages in early mouse development depend on SOX2 function
Study Officials
- PRINCIPAL INVESTIGATOR
Ahmad M Metwalley
Al Baraka Fertility Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- IVF laboratory manager
Study Record Dates
First Submitted
September 7, 2016
First Posted
September 16, 2016
Study Start
January 1, 2015
Primary Completion
December 1, 2018
Study Completion
December 2, 2018
Last Updated
January 15, 2019
Record last verified: 2019-01
Data Sharing
- IPD Sharing
- Will share
After abstract submission or after final approval for scientific paper